Epidemiology and clinical features of toxigenic culture-confirmed hospital-onset Clostridium difficile infection: a multicentre prospective study in tertiary hospitals of South Korea
Hypervirulent Clostridium difficile strains, most notably BI/NAP1/027, have been increasingly emerging in Western countries as local epidemics. We performed a prospective multicentre observational study from December 2011 to May 2012 to identify recent incidences of toxigenic culture-confirmed hospital-onset C. difficile infections (CDI) and their associated clinical characteristics in South Korea. Patients suspected of having been suffering from CDI more than 48 h after admission and aged ≥20 years were prospectively enrolled and provided loose stool specimens. Toxigenic C. difficile culture (anaerobic culture+toxin A/B/binary gene PCR) and PCR ribotyping were performed in one central laboratory. We enrolled 98 toxigenic culture-confirmed CDI-infected patients and 250 toxigenic culture-negative participants from three hospitals. The incidence of toxigenic culture-confirmed hospital-onset CDI cases was 2.7 per 10 000 patient-days. The percentage of severe CDI cases was relatively low at only 3.1 %. UK ribotype 018 was the predominant type (48.1 %). There were no hypervirulent BI/NAP1/027 isolates identified. The independent risk factors for toxigenic culture-confirmed hospital-onset CDI were invasive procedure (odds ratio (OR) 7.3, P = 0.003) and past CDI history within 3 months (OR 28.5, P = 0.003). In conclusion, the incidence and severity of CDI in our study were not higher than reported in Western countries.
AlonsoR., MartínA., PeláezT., MarínM., Rodríguez-CreixémsM., BouzaE.2005; Toxigenic status of Clostridium difficile in a large Spanish teaching hospital. J Med Microbiol 54:159–162 [View Article][PubMed]
BartlettJ. G.1994; Clostridium difficile: history of its role as an enteric pathogen and the current state of knowledge about the organism. Clin Infect Dis 18:Suppl. 4S265–S272 [View Article][PubMed]
BartlettJ. G., ChangT. W., GurwithM., GorbachS. L., OnderdonkA. B.1978; Antibiotic-associated pseudomembranous colitis due to toxin-producing clostridia. N Engl J Med 298:531–534 [View Article][PubMed]
CrobachM. J., DekkersO. M., WilcoxM. H., KuijperE. J.2009; European Society of Clinical Microbiology and Infectious Diseases (ESCMID): data review and recommendations for diagnosing Clostridium difficile-infection (CDI). Clin Microbiol Infect 15:1053–1066 [View Article][PubMed]
DelméeM., Van BroeckJ., SimonA., JanssensM., AvesaniV.2005; Laboratory diagnosis of Clostridium difficile-associated diarrhoea: a plea for culture. J Med Microbiol 54:187–191 [View Article][PubMed]
DubberkeE. R., ButlerA. M., YokoeD. S., MayerJ., HotaB., ManginoJ. E., KhanY. M., PopovichK. J., FraserV. J.2010; Multicenter study of Clostridium difficile infection rates from 2000 to 2006. Infect Control Hosp Epidemiol 31:1030–1037 [View Article][PubMed]
GoorhuisA., BakkerD., CorverJ., DebastS. B., HarmanusC., NotermansD. W., BergwerffA. A., DekkerF. W., KuijperE. J.2008; Emergence of Clostridium difficile infection due to a new hypervirulent strain, polymerase chain reaction ribotype 078. Clin Infect Dis 47:1162–1170 [View Article][PubMed]
GravelD., MillerM., SimorA., TaylorG., GardamM., McGeerA., HutchinsonJ., MooreD., KellyS.& other authors (2009; Health care-associated Clostridium difficile infection in adults admitted to acute care hospitals in Canada: a Canadian Nosocomial Infection Surveillance Program Study. Clin Infect Dis 48:568–576 [View Article][PubMed]
KimH., JeongS. H., RohK. H., HongS. G., KimJ. W., ShinM. G., KimM. N., ShinH. B., UhY.& other authors (2010; Investigation of toxin gene diversity, molecular epidemiology, and antimicrobial resistance of Clostridium difficile isolated from 12 hospitals in South Korea. Korean J Lab Med 30:491–497 [View Article][PubMed]
KimH., LeeY., MoonH. W., LimC. S., LeeK., ChongY.2011; Emergence of Clostridium difficile ribotype 027 in Korea. Korean J Lab Med 31:191–196 [View Article][PubMed]
KimJ., KangJ. O., KimH., SeoM. R., ChoiT. Y., PaiH., KuijperE. J., SandersI., FawleyW.2013a; Epidemiology of Clostridium difficile infections in a tertiary-care hospital in Korea. Clin Microbiol Infect 19:521–527 [View Article][PubMed]
KuehneS. A., CartmanS. T., HeapJ. T., KellyM. L., CockayneA., MintonN. P.2010; The role of toxin A and toxin B in Clostridium difficile infection. Nature 467:711–713 [View Article][PubMed]
KyneL., WarnyM., QamarA., KellyC. P.2000; Asymptomatic carriage of Clostridium difficile and serum levels of IgG antibody against toxin A. N Engl J Med 342:390–397 [View Article][PubMed]
KyneL., HamelM. B., PolavaramR., KellyC. P.2002; Health care costs and mortality associated with nosocomial diarrhea due to Clostridium difficile. Clin Infect Dis 34:346–353 [View Article][PubMed]
LeeY. J., ChoiM. G., LimC. H., JungW. R., ChoH. S., SungH. Y., NamK. W., ChangJ. H., ChoY. K.other authors2010; [Change of Clostridium difficile colitis during recent 10 years in Korea]. Korean J Gastroenterol 55:169–174 (in Korean) [View Article][PubMed]
LeeK., KimM. N., KimJ. S., HongH. L., KangJ. O., ShinJ. H., ParkY. J., YongD., JeongS. H., ChongY.KONSAR Group2011; Further increases in carbapenem-, amikacin-, and fluoroquinolone-resistant isolates of Acinetobacter spp. and P. aeruginosa in Korea: KONSAR study 2009. Yonsei Med J 52:793–802 [View Article][PubMed]
PépinJ., ValiquetteL., AlaryM. E., VillemureP., PelletierA., ForgetK., PépinK., ChouinardD.2004; Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity. CMAJ 171:466–472 [View Article][PubMed]
PetersonL. R., MansonR. U., PauleS. M., HacekD. M., RobicsekA., ThomsonR. B.Jr, KaulK. L.2007; Detection of toxigenic Clostridium difficile in stool samples by real-time polymerase chain reaction for the diagnosis of C. difficile-associated diarrhea. Clin Infect Dis 45:1152–1160 [View Article][PubMed]
RicciardiR., RothenbergerD. A., MadoffR. D., BaxterN. N.2007; Increasing prevalence and severity of Clostridium difficile colitis in hospitalized patients in the United States. Arch Surg 142:624–631, discussion 631 [View Article][PubMed]
ShinB. M., KuakE. Y., YooH. M., KimE. C., LeeK., KangJ. O., WhangD. H., ShinJ. H.2008a; Multicentre study of the prevalence of toxigenic Clostridium difficile in Korea: results of a retrospective study 2000–2005. J Med Microbiol 57:697–701 [View Article][PubMed]
ShinB. M., KuakE. Y., YooS. J., ShinW. C., YooH. M.2008b; Emerging toxin A−B+ variant strain of Clostridium difficile responsible for pseudomembranous colitis at a tertiary care hospital in Korea. Diagn Microbiol Infect Dis 60:333–337 [View Article][PubMed]
ShinS., KimM., KimM., LimH., KimH., LeeK., ChongY.2012; Evaluation of the Xpert Clostridium difficile assay for the diagnosis of Clostridium difficile infection. Annals Lab Med 32:355–358 [View Article][PubMed]
StubbsS. L., BrazierJ. S., O’NeillG. L., DuerdenB. I.1999; PCR targeted to the 16S-23S rRNA gene intergenic spacer region of Clostridium difficile and construction of a library consisting of 116 different PCR ribotypes. J Clin Microbiol 37:461–463[PubMed]
StubbsS., RupnikM., GibertM., BrazierJ., DuerdenB., PopoffM.2000; Production of actin-specific ADP-ribosyltransferase (binary toxin) by strains of Clostridium difficile. FEMS Microbiol Lett 186:307–312 [View Article][PubMed]
TaeC. H., JungS. A., SongH. J., KimS. E., ChoiH. J., LeeM., HwangY., KimH., LeeK.2009; The first case of antibiotic-associated colitis by Clostridium difficile PCR ribotype 027 in Korea. J Korean Med Sci 24:520–524 [View Article][PubMed]
TerhesG., UrbánE., SókiJ., HamidK. A., NagyE.2004; Community-acquired Clostridium difficile diarrhea caused by binary toxin, toxin A, and toxin B gene-positive isolates in Hungary. J Clin Microbiol 42:4316–4318 [View Article][PubMed]
ZarF. A., BakkanagariS. R., MoorthiK. M., DavisM. B.2007; A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity. Clin Infect Dis 45:302–307 [View Article][PubMed]
Epidemiology and clinical features of toxigenic culture-confirmed hospital-onset Clostridium difficile infection: a multicentre prospective study in tertiary hospitals of South Korea